Pulmonary hypertension (PH) is highly heterogeneous and despite treatment advances it
remains a life-shortening condition. There have been significant advances in imaging …

The development and implementation of personalized medicine is paramount to improving
the efficiency and efficacy of patient care. In the respiratory system, function is largely …

Pulmonary arterial hypertension (PAH) is characterized by pulmonary vascular remodeling
resulting in right ventricular (RV) dysfunction and ultimately RV failure. Mechanical stimuli …

Computational fluid dynamics (CFD) modeling of the pulmonary vasculature has the
potential to reveal continuum metrics associated with the hemodynamic stress acting on the …

Purpose To develop an estimate of pulmonary vascular resistance (PVR) using blood flow
measurements from 3D velocity‐encoded phase contract magnetic resonance imaging …

Computational fluid dynamics (CFD) is increasingly used to study blood flows in patient‐
specific arteries for understanding certain cardiovascular diseases. The techniques work …

Background Pulmonary hypertension (PH) is a life‐threatening. Differentiation pulmonary
arterial hypertension (PAH) from pulmonary venous hypertension (PVH) is important due to …

Many pathophysiologic processes of pulmonary arterial hypertension (PAH), namely, excess
vasoconstriction, vascular remodeling and in situ thrombosis, involve the coagulation …

Developing new approaches for vascularizing synthetic tissue systems will have a
tremendous impact in diverse areas. One area where this is particularly important is …

Background/Objectives. The objective of this study was to evaluate the utility of circulating
miRNAs as biomarkers of vascular function in pediatric pulmonary hypertension. Method …